Sponsor Pipeline

Upstream Bio Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
0
Recruiting
2
Disease Areas
3
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-21 NCT06981078
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD		 Trial sites reduced: 323 -> 242 locations
2026-07-21 NCT06981078
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD		 date change Primary completion moved earlier: 2028-04 -> 2027-10
2026-07-21 NCT06981078
A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD		 date change Completion moved earlier: 2028-07 -> 2027-11
Active Trials by Phase
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06966479 A Long-Term Safety and Efficacy Study of Verekitug (UPB-101) in Adult Participants With… Severe Asthma Active, Not Recruiting
NCT06981078 A Study to Assess the Efficacy and Safety of Verekitug in Participants With COPD Chronic Obstructive Pulmonary Disease Active, Not Recruiting
Disease Areas
Asthma (1) COPD (1)
Get alerts when Upstream Bio Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free